Market Executive Summary

The global market for Structural Heart Disease Interventional Device was estimated to be worth US$ 85400 million in 2023 and is forecast to a readjusted size of US$ 268070 million by 2030 with a CAGR of 18.3% during the forecast period 2024-2030.

The global key companies of Structural Heart Disease Interventional Device include Abbott Laboratories, Boston Scientific, Edwards Lifesciences, Medtronic, Terumo, B. Braun, Lepu Medical, Koninklijke Philips NV and Biosensors International, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Structural Heart Disease Interventional Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Structural Heart Disease Interventional Device by region & country, by Type, and by Application.

The Structural Heart Disease Interventional Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Structural Heart Disease Interventional Device.

Global Structural Heart Disease Interventional Device Companies Covered

Abbott Laboratories, Boston Scientific, Edwards Lifesciences, Medtronic, Terumo, B. Braun, Lepu Medical, Koninklijke Philips NV, Biosensors International, Meril Life Sciences.

Global Structural Heart Disease Interventional Device Market, Segment by Type

Percutaneous Interventional Devices

Thoracotomy Instruments

Global Structural Heart Disease Interventional Device Market, Segment by Application

Congenital Heart Disease

Valvular Disease

Cardiomyopathy

Others

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Structural Heart Disease Interventional Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Structural Heart Disease Interventional Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Structural Heart Disease Interventional Device in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.